Abstract:AbstractTo identify the genetic determinants of colon tumorigenesis, 268 male mice from 33 inbred strains derived from different genealogies were treated with azoxymethane (AOM; 10 mg/kg) once a week for six weeks to induce colon tumors. Tumors were localized exclusively within the distal colon in each of the strains examined. Inbred mouse strains exhibit a large variability in genetic susceptibility to AOM-induced colon tumorigenesis. The mean colon tumor multiplicity ranged from 0 to 38.6 (mean = 6.5 ± 8.6) and tumor volume ranged from 0 to 706.5 mm3 (mean = 87.4 ± 181.9) at 24 weeks after the first dose of AOM. AOM-induced colon tumor phenotypes are highly heritable in inbred mice, and 68.8% and 71.3% of total phenotypic variation in colon tumor multiplicity and tumor volume, respectively, are attributable to strain-dependent genetic background. Using 97,854 single-nucleotide polymorphisms, we carried out a genome-wide association study (GWAS) of AOM-induced colon tumorigenesis and identified a novel susceptibility locus on chromosome 15 (rs32359607, P = 6.31 × 10–6). Subsequent fine mapping confirmed five (Scc3, Scc2, Scc12, Scc8, and Ccs1) of 16 linkage regions previously found to be associated with colon tumor susceptibility. These five loci were refined to less than 1 Mb genomic regions of interest. Major candidates in these loci are Sema5a, Fmn2, Grem2, Fap, Gsg1l, Xpo6, Rabep2, Eif3c, Unc5d, and Gpr65. In particular, the refined Scc3 locus shows high concordance with the human GWAS locus that underlies hereditary mixed polyposis syndrome. These findings increase our understanding of the complex genetics of colon tumorigenesis, and provide important insights into the pathways of colorectal cancer development and might ultimately lead to more effective individually targeted cancer prevention strategies. Mol Cancer Res; 10(1); 66–74. ©2011 AACR.

Genomic approaches to identification of tumour-susceptibility genes using mouse models.

Novel Approaches to Identify Low-Penetrance Cancer Susceptibility Genes Using Mouse Models.

Anti-tumor immune response varies among individuals: A gene expression profiling of mouse melanoma

Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.

Data from Genome-Wide Association and Fine Mapping of Genetic Loci Predisposing to Colon Carcinogenesis in Mice

Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

[Whole-genome sequencing: a new approach for understanding of pathogenesis and individualized treatment of cancer].

Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice

The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis

In vivo functional screening for systems-level integrative cancer genomics

Analyses of Tumor-Suppressor Genes in Germline Mouse Models of Cancer

Mouse models of DNA mismatch repair in cancer research

Mouse Systems Genetics as a Prelude to Precision Medicine

Toxicogenomics and cancer susceptibility: advances with next-generation sequencing.

Conditional mouse models of sporadic cancer

Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer

If you give a mouse a mutation: comparing the therapeutic utility of renowned mouse models of human cancers

Beyond genetics: driving cancer with the tumour microenvironment behind the wheel

Polymorphic Genetic Control of Tumor Invasion in a Mouse Model of Pancreatic Neuroendocrine Carcinogenesis

Toxicogenomics and Cancer Susceptibility: Advances with Next-Generation Sequencing